Isofol Medical AB (OSTO:ISOFOL) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Isofol Medical AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Isofol Medical AB's Free Cash Flow for the three months ended in Dec. 2023 was kr-7.04 Mil. Isofol Medical AB's Revenue for the three months ended in Dec. 2023 was kr0.00 Mil. Therefore, Isofol Medical AB's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Isofol Medical AB's current FCF Yield % is -49.43%.

The historical rank and industry rank for Isofol Medical AB's FCF Margin % or its related term are showing as below:

OSTO:ISOFOL' s FCF Margin % Range Over the Past 10 Years
Min: -2067266.67 Med: -1505.67 Max: -431.77
Current: -7286.69

During the past 9 years, the highest FCF Margin % of Isofol Medical AB was -431.77%. The lowest was -2067266.67%. And the median was -1505.67%.

OSTO:ISOFOL's FCF Margin % is ranked worse than
90.11% of 1041 companies
in the Biotechnology industry
Industry Median: -143.92 vs OSTO:ISOFOL: -7286.69

Isofol Medical AB FCF Margin % Historical Data

The historical data trend for Isofol Medical AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isofol Medical AB FCF Margin % Chart

Isofol Medical AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-431.77

-840.94

-1,505.67

-7,286.55

Isofol Medical AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-2,402.48	-3,639.94	-	-	-

Competitive Comparison of Isofol Medical AB's FCF Margin %

For the Biotechnology subindustry, Isofol Medical AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Isofol Medical AB's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Isofol Medical AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Isofol Medical AB's FCF Margin % falls into.

Isofol Medical AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Isofol Medical AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-52.536	/	0.721
	=	-7,286.55 %

Isofol Medical AB's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-7.038	/	0
	=	%

Isofol Medical AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Isofol Medical AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Isofol Medical AB (OSTO:ISOFOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Isofol Medical AB (OSTO:ISOFOL) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

5IU:Germany

Address

Arvid Wallgrens Backe 20, Biotech Center, Gothenburg, SWE, SE-413 46

Website

http://www.isofol.se

Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. Its products are used to increase efficacy and reduce the side effects of antimetabolite cancer treatment.

Isofol Medical AB (OSTO:ISOFOL) Headlines

No Headlines